NOVO NORDISK A S NVO (NYSE) $ 51.71 Change: -2.49 -4.82% | Volume: 520,503

NOVO- NORDISK AS

Company Information

Ticker Symbol: NVO
Exchange: NYSE
Contact Info: Novo All¿¿ Bagsvaerd 41 61 324 11 11
CEO/President: Lars Rebien S¿¿rensen
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Share Information

Shares Outstanding: 623,500 (000) Market Value: 33,793,700 ($000)
Percentage of Inst.Shareholders: 4.55% Number of Inst.Shareholders: N/A%
Last Quarter Sales: 1489.00 ($Mil.) Last Quarter Net Income: 332.00 ($Mil.)
Last Quarter EPS: 0.53 P/E Ratio: 25
Most Recent Earnings: Earnings Per Share: 2.16
Most Recent Split: 2-1 on 12/17/07 Annual Dividend Rate: .68
Most Recent Dividend: 0.679 on 03/13/08 Annual Dividend Yield: 1.25%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -18.50 18.67
MERCK CO INC -32.60 34.17
JOHNSON AND JOH +17.90 70.45
SCHERING PLOUGH -29.30 19.16
BRISTOL MYERS S -18.00 21.50